ScholarIQanswers from OpenAlex
GGD Amsterdam
InstitutionResearch output, impact & collaborations
GGD Amsterdam is a institution indexed in ScholarIQ from OpenAlex.
What is known about GGD Amsterdam?
ScholarIQrecord summary
GGD Amsterdam is a research organisation in Amsterdam, NL. OpenAlex records 10,159 works and 584,717 citations for it. 2,892 researchers list it as their most recent affiliation.
How many works does GGD Amsterdam have?
ScholarIQindexed works
GGD Amsterdam has 10,159 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does GGD Amsterdam have?
ScholarIQcitation count
GGD Amsterdam has 584,717 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at GGD Amsterdam?
ScholarIQresearcher count
GGD Amsterdam has 2,892 researchers in the ScholarIQ index.
What is the average h-index at GGD Amsterdam?
ScholarIQavg h-index
GGD Amsterdam has an average h-index of 85.1 in OpenAlex.
What is the ROR of GGD Amsterdam?
ScholarIQror
The ROR for GGD Amsterdam is on the source record.
What is the OpenAlex record for GGD Amsterdam?
ScholarIQopenalex
The OpenAlex for GGD Amsterdam is on the source record.
Who are the most-cited researchers behind GGD Amsterdam?
ScholarIQtop researchers by citations
What are the most-cited papers on GGD Amsterdam?
ScholarIQmost cited works
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
Michael Marmot, Tola Atinmo, T. Byers, Jun Chen, T Hirohata, Alun C. Jackson, William H. James, L N Kolonel, Shiriki Kumanyika, Claus Leitzmann, J Mann, Hilary J. Powers, K. Rama Reddy, Elio Ríboli, JA Rivera, Arthur Schatzkin, Jacob C. Seidell, David E. G. Shuker, Ricardo Uauy, Walter C. Willett, Steven H. Zeisel
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem A. Bemelman, Silvio Danese, Jean Yves Mary, David T. Rubin, Jean‐Frédéric Colombel, Laurent Peyrin‐Biroulet, Iris Dotan, María T. Abreu, Axel Dignaß
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
Neil K. Aaronson, Martín Müller, Peter Cohen, Marie‐Louise Essink‐Bot, Minne Fekkes, Robbert Sanderman, Mirjam A. G. Sprangers, Adrienne te Velde, Erik Verrips
Integrating response shift into health-related quality of life research: a theoretical model
Mirjam A. G. Sprangers, Carolyn E. Schwartz
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Laurent Peyrin‐Biroulet, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Willem A. Bemelman, Robert V. Bryant, Geert D’Haens, Iris Dotan, Marla C. Dubinsky, Brian G. Feagan, Gionata Fiorino, Richard B. Gearry, Suneeta Krishnareddy, Péter L. Lakatos, Edward V. Loftus, Philippe Marteau, Pia Munkholm, Travis B. Murdoch, Íngrid Ordás, Remo Panaccione, Robert H. Riddell, Joannie Ruel, David T. Rubin, Mark Samaan, Corey A. Siegel, Mark S. Silverberg, Jaap Stoker, S Schreiber, Simon Travis, Gert Van Assche, Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel
How much of the research on GGD Amsterdam is open access?
ScholarIQopen access share
58%OPEN ACCESS